Cite
HARVARD Citation
Bozon, A. et al. (n.d.). P604 Infection Risk in Elderly Patients with Inflammatory Bowel Disease under anti-TNF, ustekinumab or vedolizumab biologic therapies: A Prospective Multicenter observational One-Year follow-up comparative study. Journal of Crohn's and colitis. p. i537. [Online].